Abstract
Placebo and three doses of methylphenidate (MPH) were crossed with 3 levels of behavioral modification (no behavioral modification, NBM; low-intensity behavioral modification, LBM; and high-intensity behavior modification, HBM) in the context of a summer treatment program (STP). Participants were 48 children with ADHD, aged 5–12. Behavior was examined in a variety of social settings (sports activities, art class, lunch) that are typical of elementary school, neighborhood, and after-school settings. Children received each behavioral condition for 3 weeks, order counterbalanced across groups. Children concurrently received in random order placebo, 0.15 mg/kg/dose, 0.3 mg/kg/dose, or 0.6 mg/kg/dose MPH, 3 times daily with dose manipulated on a daily basis in random order for each child. Both behavioral and medication treatments produced highly significant and positive effects on children’s behavior. The treatment modalities also interacted significantly. Whereas there was a linear dose–response curve for medication in NBM, the dose–response curves flattened considerably in LBM and HBM. Behavior modification produced effects as large as moderate doses, and on some measures, high doses of medication. These results replicate and extend to social-recreational settings previously reported results in a classroom setting from the same sample (Fabiano et al., School Psychology Review, 36, 195–216, 2007). Results illustrate the importance of taking dosage/intensity into account when evaluating combined treatments; there were no benefits of combined treatments when the dosage of either treatment was high but combination of the low-dose treatments produced substantial incremental improvement over unimodal treatment.
Similar content being viewed by others
References
Abikoff, H., Hechtman, L., Klein, R. G., Weiss, G., Fleiss, K., Etcovitch, J., et al. (2004). Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 802–811. doi:10.1097/01.chi.0000128791.10014.ac.
Abramowitz, A. J., Eckstrand, D., O'Leary, S. G., & Dulcan, M. K. (1992). ADHD children’s responses to stimulant medication and two intensities of a behavioral intervention. Behavior Modification, 16, 193–203. doi:10.1177/01454455920162003.
Carlson, C. L., Pelham, W. E., Milich, R., & Dixon, J. (1992). Single and combined effects of methylphenidate and behavior therapy on the classroom performance of children with ADHD. Journal of Abnormal Child Psychology, 20, 213–232. doi:10.1007/BF00916549.
Chronis, A. M., Pelham, W. E., Gnagy, E. M., Roberts, J. E., & Aronoff, H. R. (2003). The impact of late-afternoon stimulant dosing for children with ADHD on parent and parent–child domains. Journal of Clinical Child & Adolescent Psychology, 32, 118–126. doi:10.1207/S15374424JCCP3201_11.
Chronis, A. M., Fabiano, G. A., Gnagy, E. M., Onyango, A. N., Pelham, W. E., Williams, A., et al. (2004). An evaluation of the summer treatment program for children with attention-deficit/hyperactivity disorder using a treatment withdrawal design. Behavior Therapy, 35, 561–585. doi:10.1016/S0005-7894(04)80032-7.
DuPaul, G. J., & Eckert, T. L. (1997). The effects of school-based interventions for attention deficit hyperactivity disorder: a meta-analysis. School Psychology Review, 26, 5–27.
Fabiano, G. A., Pelham, W. E., Waschbusch, D., Gnagy, E. M., Lahey, B. B., Chronis, A. M., et al. (2006). A practical impairment measure: psychometric properties of the impairment rating scale in samples of children with attention-deficit/hyperactivity disorder and two school-based samples. Journal of Clinical Child and Adolescent Psychology, 35, 369–385. doi:10.1207/s15374424jccp3503_3.
Fabiano, G. A., Pelham, W. E., Gnagy, E. M., Burrows-MacLean, L., Coles, E. K., Chacko, A., et al. (2007). The single and combined effects of multiple intensities of behavior modification and multiple intensities of methylphenidate in a classroom setting. School Psychology Review, 36, 195–216.
Fabiano, G. A., Pelham, W. E., Coles, E. K., Gnagy, E. M., Chronis, A. M., & O’Connor, B. C. (2009). A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clinical Psychology Review, 29, 129–140. doi:10.1016/j.cpr.2008.11.001.
Hoza, B., Pelham, W. E., Sams, S. E., & Carlson, C. (1992). An examination of the “dosage” effects of both behavior therapy and methylphenidate on the classroom performance of two ADHD children. Behavior Modification, 16, 164–192. doi:10.1177/01454455920162002.
Hupp, S. D. A., Reitman, D., Northup, J., O’Callahan, P., & LeBlanc, M. (2002). The effects of delayed rewards, tokens, and stimulant medication on sportsmanlike behavior with ADHD-diagnosed children. Behavior Modification, 26, 148–162. doi:10.1177/0145445502026002002.
Jadad, A. R., Boyle, M., Cunningham, C., Kim, M., & Schachar, R. (1999). Treatment of attention-deficit hyperactivity disorder. Evidence Report/Technology Assessment No. 11. Rockville: Agency for Healthcare Research and Quality.
Jensen, P. S., Arnold, L. E., Swanson, J. M., Vitiello, B., Abikoff, H. B., Greenhill, L. L., et al. (2007). 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 989–1005. doi:10.1097/CHI.0b013e3180686d48.
Klein, R. G., & Abikoff, H. (1997). Behavior therapy and methylphenidate in the treatment of children with ADHD. Journal of Attention Disorders, 2, 89–114. doi:10.1177/108705479700200203.
Kolko, D. J., Bukstein, O. G., & Barron, J. (1999). Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 578–586. doi:10.1097/00004583-199905000-00020.
Loney, J., & Milich, R. (1982). Hyperactivity, inattention, and aggression in clinical practice. In M. Wolraich & D. K. Routh (Eds.), Advances in developmental and behavioral pediatrics (Vol. 3, pp. 113–147). Greenwich: JAI Press.
MTA Cooperative Group. (1999a). 14-month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Archives of General Psychiatry, 56, 1073–1086. doi:10.1001/archpsyc.56.12.1073.
MTA Cooperative Group. (1999b). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1088–1096. doi:10.1001/archpsyc.56.12.1088.
MTA Cooperative Group. (2004). National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder (ADHD). Pediatrics, 113, 754–761. doi:10.1542/peds.113.4.754.
Northup, J., Fusilier, I., Swanson, V., Huerte, J., Bruce, T., Freeland, J., et al. (1999). Further analysis of the separate and interactive effects of methylphenidate and common classroom contingencies. Journal of Applied Behavior Analysis, 32, 35–50. doi:10.1901/jaba.1999.32-35.
O’Connor, B., Fabiano, G. A., Waschbusch, D. A., Belin, P. J., Gnagy, E. M., Pelham, W. E., et al. (2013). Effects of a summer treatment program on functional sports outcomes in young children with ADHD. Manuscript submitted for publication.
Page, T., Fabiano, G., Greiner, A., Waxmonsky, J., Pelham W.E. III, Gnagy, E., et al. (2013). Comparative cost analysis of sequential, adaptive, behavioral, pharmacological, and combined treatments for ADHD. Manuscript submitted for publication.
Pelham, W. E. (1993). Pharmacotherapy for children with attention-deficit hyperactivity disorder. School Psychology Review, 22, 199–227.
Pelham, W. E. Jr., Burrows-MacLean, L., Massetti, G., Coles, E. K., Wymbs, B. T., Chacko, A., et al. (2013). Behavioral and pharmacological treatment for children with ADHD in the home setting. Manuscript submitted for publication.
Pelham, W. E. Jr., Fabiano, G., Waxmonsky, J., Greiner, A., Gnagy, E., & Murphy, S. (2013). Treatment sequencing for ADHD: An adaptive, multiple-randomization study of medication and behavioral interventions. Manuscript submitted for publication.
Pelham, W. E., & Fabiano, G. A. (2008). Evidence-based psychosocial treatment for attention deficit/hyperactivity disorder: an update. Journal of Clinical Child and Adolescent Psychology, 37, 185–214. doi:10.1080/15374410701818681.
Pelham, W. E., & Waschbusch, D. A. (1999). Behavioral intervention in ADHD. In H. C. Quay & A. Hogan (Eds.), Handbook of disruptive behavior disorders (pp. 255–278). New York: Plenum.
Pelham, W. E., Bender, M. E., Caddell, J., Booth, S., & Moorer, S. H. (1985). Methylphenidate and children with attention deficit disorder: dose effects on classroom academic and social behavior. Archives of General Psychiatry, 42, 948–952. doi:10.1001/archpsyc.1985.01790330028003.
Pelham, W. E., Greenslade, K. E., Vodde-Hamilton, M. A., Murphy, D. A., Greenstein, J. J., Gnagy, E. M., et al. (1990a). Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and Pemoline. Pediatrics, 86, 226–237.
Pelham, W. E., McBurnett, K., Harper, G. W., Murphy, D. A., Milich, R., Clinton, J., et al. (1990b). Methylphenidate and baseball playing in ADHD children: who’s on first? Journal of Consulting and Clinical Psychology, 58, 130–133. doi:10.1037/0022-006X.58.1.130.
Pelham, W. E., Gnagy, E. M., Greenslade, K. E., & Milich, R. (1992). Teacher ratings of DSM-III-R symptoms of the disruptive behavior disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 210–218. doi:10.1097/00004583-199203000-00006.
Pelham, W. E., Carlson, C., Sams, S. E., Vallano, G., Dixon, M. J., & Hoza, B. (1993). Separate and combined effects of methylphenidate and behavior modification on boys with ADHD in the classroom. Journal of Consulting and Clinical Psychology, 61, 506–515. doi:10.1037/0022-006X.61.3.506.
Pelham, W. E., Greiner, A. R., & Gnagy, E. M. (1997). Summer treatment program manual. Buffalo: Comprehensive Treatment for Attention Deficit Disorders, Inc.
Pelham, W. E., Lang, A. R., Atkeson, B., Murphy, D. A., Gnagy, E. M., Greiner, A. R., et al. (1998). Effects of deviant child behavior on parental alcohol consumption. The American Journal on Addictions, 7, 103–114. doi:10.1111/j.1521-0391.1998.tb00325.x.
Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., et al. (1999). A comparison of Ritalin and Adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder. Pediatrics, 103. Retrieved from: http://www.pediatrics.org/cgi/content/full/103/4/e43.
Pelham, W. E., Gnagy, E. M., Greiner, A. R., Hoza, B., Hinshaw, S. P., Swanson, J. M., et al. (2000). Behavioral vs. behavioral and pharmacological treatment in ADHD children attending a summer treatment program. Journal of Abnormal Child Psychology, 28, 507–526. doi:10.1023/A:1005127030251.
Pelham, W. E., Gnagy, E. M., Burrows-MacLean, L., Williams, A., Fabiano, G. A., Morrisey, S. M., et al. (2001). Once-a-day Concerta™ methylphenidate versus t.i.d. methylphenidate in laboratory and natural settings. Pediatrics, 107. Retrieved from: http://www.pediatrics.org/cgi/content/full/107/6/e105. doi: 10.1542/peds.107.6.e105.
Pelham, W. E., Burrows-MacLean, L., Gnagy, E. M., Fabiano, G. A., Coles, E. K., Tresco, K. E., et al. (2005). Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Experimental and Clinical Psychopharmacology, 13, 111–126. doi:10.1037/1064-1297.13.2.111.
Pelham, W. E., Gnagy, E. M., Greiner, A. R., Waschbusch, D. A., Fabiano, G. A., & Burrows-MacLean, L. (2010). Summer treatment programs for attention deficit/hyperactivity disorder. In J. R. Weisz & A. E. Kazdin (Eds.), Evidence-based psychotherapies for children and adolescents (2nd ed., pp. 277–292). New York: The Guilford Press.
Poulton, A. (2005). Growth on stimulant medication; clarifying the confusion: a review. Archives of Disease in Childhood, 90, 801–806. doi:10.1136/adc.2004.056952.
Scheffler, R. M., Hinshaw, S. P., Modrek, S., & Levine, P. (2007). The global market for ADHD medications. Health Affairs, 26, 450–457. doi:10.1377/hlthaff.26.2.450.
Stage, S. A., & Quiroz, D. R. (1997). A meta-analysis of interventions to decrease disruptive classroom behavior in public education settings. School Psychology Review, 26, 333–368.
Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. (2011). ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of Attention-Deficit/Hyperactivity Disorder in children and adolescents. Pediatrics, 128, 2011–2654. doi:10.1542/peds.2011-2654.
Swanson, J. M., Elliott, G. R., Greenhill, L. L., Wigal, T., Arnold, L. E., Vitiello, B., et al. (2007). Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1014–1026. doi:10.1097/chi.0b013e3180686d7e.
Van der Oord, S., Prins, P. J. M., Oosterlan, J., & Emmelkamp, P. M. G. (2008). Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clinical Psychology Review, 28, 783–800. doi:10.1016/j.cpr.2007.10.007.
Waschbusch, D. A., Cunningham, C. E., Pelham, W. E., Rimas, H. L., Greiner, A. R., Gnagy, E. M., et al. (2011). A discrete choice conjoint experiment to evaluate parent preferences for treatment of young, medication naïve children with ADHD. Journal of Clinical Child and Adolescent Psychology, 40(4), 546–561. doi:10.1080/15374416.2011.581617.
Wechsler, D. (1991). Wechsler intelligence scale for children (3rd ed.). San Antonio: The Psychological Corporation.
Werry, J., & Sprague, R. (1974). Methylphenidate in children: effect of dosage. Australian and New Zealand Journal of Psychiatry, 8, 9–19. doi:10.3109/00048677409159770.
Acknowledgments
This study was funded by a grant from the National Institute of Mental Health (MH62946). During the conduct of this study and preparation of this report, Dr. Pelham was also funded by grants from the National Institutes of Health (MH62946, MH69614, MH53554, MH69434, MH65899, MH78051,MH062946, NS39087, AA11873, DA12414, HD42080), and the Institute of Education Sciences (L03000665A). Dr. Fabiano was supported in part by a Ruth S. Kirschstein National Research Service Award Predoctoral Fellowship (1F31MH064243-01A1) and by the Department of Education, Institute of Education Sciences (R324J06024,, R324B06045).
Author information
Authors and Affiliations
Corresponding author
Additional information
This research was funded by a grant from the National Institute of Mental Health (MH62946). Dr. Pelham was also supported in part by grants from the National Institute of Mental Health (MH092466, MH53554, MH065899, MH62988), the Institute of Education Sciences (R37A120169 LO30000665A, R324B06045), the National Institute of Alcohol Abuse and Alcoholism (AA11873), the National Institute on Drug Abuse (DA12414, DA12986), and the National Institute of Child Health and Human Development (HD040935).
Rights and permissions
About this article
Cite this article
Pelham, W.E., Burrows-MacLean, L., Gnagy, E.M. et al. A Dose-Ranging Study of Behavioral and Pharmacological Treatment in Social Settings for Children with ADHD. J Abnorm Child Psychol 42, 1019–1031 (2014). https://doi.org/10.1007/s10802-013-9843-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10802-013-9843-8